Paper648565
Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease.
Tattersall MH and 5 others. Eur J Cancer (1965), 1978. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. Papers, record 648565. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/648565
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melphalan | Major topic |
| Neoplasms | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Female | |
| Half-Life | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22922522 | Fifty years of melphalan use in hematopoietic stem cell transplantation. | Biol Blood Marrow Transplant | 2013 | https://conductscience.org/library/papers/22922522 | PubMed |
| 16430310 | Mass balance studies, with a focus on anticancer drugs. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16430310 | PubMed |
| 15752378 | Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation. | Br J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/15752378 | PubMed |
| 8462127 | Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8462127 | PubMed |
| 7307234 | The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systems. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7307234 | PubMed |
| 7296753 | Melphalan estimation by quantitative thin-layer chromatography. Observations on melphalan hydrolysis in vitro and pharmacokinetics in rabbits. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7296753 | PubMed |
| 7139852 | Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7139852 | PubMed |
| 7105381 | In vitro degradation of L-phenylalanine mustard (L-PAM). | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7105381 | PubMed |
| 6994913 | The practical benefits of pharmacokinetics in the use of antineoplastic agents. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6994913 | PubMed |
| 6705135 | Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6705135 | PubMed |
| 6678879 | Pharmacokinetics of high dose melphalan. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678879 | PubMed |
| 3948305 | The effect of food on oral melphalan absorption. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3948305 | PubMed |
| 3948304 | Pharmacokinetics of high-dose melphalan in children and adults. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3948304 | PubMed |
| 3888428 | Anticancer drug pharmacodynamics. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3888428 | PubMed |
| 3690803 | Variability of tumor response to chemotherapy. I. Contribution of host heterogeneity. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3690803 | PubMed |
| 3594717 | The effect of dietary amino acids on the gastrointestinal absorption of melphalan and chlorambucil. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3594717 | PubMed |
| 3516430 | Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3516430 | PubMed |
| 3349564 | A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3349564 | PubMed |
| 3311530 | Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311530 | PubMed |
| 3191937 | The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3191937 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/648565
GET https://conductscience.org/api/papers/v1/648565/cited_by?page=2